FI20080012A0 - Pharmaceutical formulations - Google Patents

Pharmaceutical formulations

Info

Publication number
FI20080012A0
FI20080012A0 FI20080012A FI20080012A FI20080012A0 FI 20080012 A0 FI20080012 A0 FI 20080012A0 FI 20080012 A FI20080012 A FI 20080012A FI 20080012 A FI20080012 A FI 20080012A FI 20080012 A0 FI20080012 A0 FI 20080012A0
Authority
FI
Finland
Prior art keywords
pharmaceutical formulations
formulations
pharmaceutical
Prior art date
Application number
FI20080012A
Other languages
Finnish (fi)
Swedish (sv)
Inventor
Erkki Heilakka
Giovanni Politi
Original Assignee
Atacama Labs Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Atacama Labs Oy filed Critical Atacama Labs Oy
Priority to FI20080012A priority Critical patent/FI20080012A0/en
Publication of FI20080012A0 publication Critical patent/FI20080012A0/en

Links

FI20080012A 2008-01-08 2008-01-08 Pharmaceutical formulations FI20080012A0 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FI20080012A FI20080012A0 (en) 2008-01-08 2008-01-08 Pharmaceutical formulations

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FI20080012A FI20080012A0 (en) 2008-01-08 2008-01-08 Pharmaceutical formulations

Publications (1)

Publication Number Publication Date
FI20080012A0 true FI20080012A0 (en) 2008-01-08

Family

ID=39004240

Family Applications (1)

Application Number Title Priority Date Filing Date
FI20080012A FI20080012A0 (en) 2008-01-08 2008-01-08 Pharmaceutical formulations

Country Status (1)

Country Link
FI (1) FI20080012A0 (en)

Similar Documents

Publication Publication Date Title
CY2018030I1 (en) PHARMACEUTICAL FORM 514
LTC2140867I2 (en) Pharmaceutical composition
BRPI0820381A2 (en) Pharmaceutical Formulations
SMT201700095B (en) COMPOSITION PHARMACEUTICAL PER INALAZIONE
BRPI0920521A2 (en) pharmaceutical combination
DK3061445T3 (en) Highly concentrated pharmaceutical formulations
SMT201400069B (en) Pharmaceutical formulation
BRPI0721651A2 (en) PHARMACEUTICAL COMPOSITION
DK3097925T3 (en) PHARMACEUTICAL COMPOSITION
DK3492069T3 (en) PHARMACEUTICAL COMPOSITIONS INCLUDING IRON-OXY-HYDROXIDE
BRPI1004940A2 (en) pharmaceutical composition
DK2328601T3 (en) Linaclotide-containing formulations for oral administration
BRPI0814188A2 (en) FORMULATIONS
BRPI1012539A2 (en) pharmaceutical compositions
BRPI1015939A2 (en) pharmaceutical composition
DK2120884T3 (en) Pharmaceutical composition
DK2285413T3 (en) Pharmaceutical composition
BRPI0921654A2 (en) pharmaceutical formulation
IT1394400B1 (en) PHARMACEUTICAL COMPOSITIONS
DK2391349T3 (en) Pharmaceutical composition comprising 2-oco-1-pyrrolidine derivatives
BRPI0921313A2 (en) pharmaceutical composition
DK2271618T3 (en) Pharmaceutical compounds
BRPI0820198A2 (en) pharmaceutical compositions
BR112012003149A2 (en) pharmaceutical composition
BR112012001340A2 (en) pharmaceutical compositions

Legal Events

Date Code Title Description
FA Application withdrawn